Mednet Logo

What is your approach towards initial regimen and tapering of mycophenolate in scleroderma?

Does your approach differ if treating more ILD versus cutaneous disease?
2 Answers
Mednet Member
Mednet MemberInvited Expert
Rheumatology · Yale School of Medicine
Answered on

I start low and go slow to avoid diarrhea and abdominal upset. I give the patient 250 mg tablets and tell them to increase as tolerated to 1000 mg PO BID. I write Cellcept 1000 mg PO BID to the pharmacy to avoid questions. I seldom increase beyond 1000 mg PO BID because it seems like pushing the dos...

Join for free or sign in to see the full answer

Mednet Member
Mednet MemberInvited Expert
Rheumatology · Mayo Clinic
Answered on

My goal is to get the patient to tolerate it first, and then uptitrate to a goal dose of 2-3 g/d. 3 g if permissible for the first year (for both progressive cutaneous and/or ILD) and then reduce after gaining improvement or significant stability to 2g daily for maintenance for at least 3-4 years. T...

Join for free or sign in to see the full answer